Root Node

You are Dr. Budi, a general practitioner. You are conducting a scheduled teleconsultation from your referral hospital in the city. The patient, Mr. Hartono, a 67-year-old man, is at a satellite clinic in a remote area, accompanied by the clinic nurse, Nurse Rina.

Mr. Hartono was diagnosed with Rapid Molecular Test TB 4 weeks ago and started on Category 1 FDC (Fixed-Dose Combination) anti-tuberculosis therapy (4-FDC: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) daily, the patient was already know to consume the anti-tuberculosis drug because the doctor's suggestion from the first telemedicine. This is his second scheduled tele-monitoring session.